BriaCell Therapeutics Corp - Warrants (24/02/2025)
BCTXW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.51K
Close$
$0.04
3955.6% upside
Current Fair Value
3955.6% upsideUndervalued by 3955.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4,510.00 |
|---|---|
| Enterprise Value | $-9,847,925.00 |
| Earnings per Share | $-6.97 |
| Beta | 2.03 |
| Outstanding Shares | 5,010,907 |
Return
| Return on Equity | -223.11% |
|---|---|
| Return on Assets | -147.22% |
| Return on Invested Capital | -195.76% |
Valuation & Multiples
| P/E Ratio | -0.42 |
|---|---|
| PEG | -0.85 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.04 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BriaCell Therapeutics Corp
17 employees
CEO: William V. Williams
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.